ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borowiec, J. W.
Right arrow Articles by Thelin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borowiec, J. W.
Right arrow Articles by Thelin, S.

The Annals of Thoracic Surgery, Vol 55, 1540-1545, Copyright © 1993 by The Society of Thoracic Surgeons


ARTICLES

Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study

JW Borowiec, A Bylock, J van der Linden and S Thelin
Department of Thoracic and Cardiovascular Surgery, University Hospital, Uppsala, Sweden.

Deleterious effects of cardiopulmonary bypass (CPB) are partly sequelae of blood-foreign surface reactions. Coating the inner surfaces of CPB sets with heparin has been shown to decrease activation of humoral cascade systems. The aim of this study was to investigate whether the heparin-coated CPB sets influence adhesion of blood cells to surfaces of arterial filters during CPB. Thirty-one patients undergoing coronary artery bypass grafting were studied. In the control group (C) standard CPB sets and standard doses of heparin (300 IU/kg) were employed; in the HC (heparin-coated) group, heparin-coated CPB sets and reduced heparin doses (range, 150 to 225 IU/kg) were used. Two additional groups were also studied; group FC (coated filter), with standard CPB sets and heparin-coated arterial filters (heparin dose, 300 IU/kg), and group OC (uncoated filter), with heparin-coated CPB sets and standard arterial filters (heparin dose, 300 IU/kg). The inner surfaces of the arterial filters were examined after CPB with scanning electron microscopy. Scanning electron microscopy demonstrated almost clean surfaces in heparin-coated filters even when other parts of the circuit were uncoated. Using an arbitrary adhesion score, significant differences between the groups were noted in the adhesion grade; it was lowest in group HC (2.2 +/- 0.27 [mean +/- standard error of the mean]) versus group C (5.4 +/- 0.53; p < 0.001). In group FC it was marginally higher than in group HC but almost significantly lower than in group OC (2.6 +/- 0.68 versus 5.4 +/- 0.81; p = 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
D C Whitaker, J A Stygall, S P Newman, and M J. Harrison
The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies
Perfusion, December 1, 2001; 16(6): 433 - 446.
[Abstract] [PDF]


Home page
PerfusionHome page
L B Mongero, J R Beck, H E Manspeizer, E J Heyer, K Lee, T A Spanier, and C R Smith
Cardiac surgical patients exposed to heparin-bonded circuits develop less postoperative cerebral dysfunction than patients exposed to non-heparin-bonded circuits
Perfusion, March 1, 2001; 16(2): 107 - 111.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Nakajima, K. Kawazoe, K. Ishibashi, Y. Kubota, T. Sasaki, H. Izumoto, and T. Nitatori
Reduction of heparin dose is not beneficial to platelet function
Ann. Thorac. Surg., July 1, 2000; 70(1): 186 - 190.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. L. Lazar, Y. Bao, S. Rivers, P. R. Treanor, and R. J. Shemin
Decreased incidence of arterial thrombosis using heparin-bonded intraaortic balloons
Ann. Thorac. Surg., February 1, 1999; 67(2): 446 - 449.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
C B. Mahoney
Heparin-bonded circuits: clinical outcomes and costs
Perfusion, May 1, 1998; 13(3): 192 - 204.
[Abstract] [PDF]


Home page
PerfusionHome page
S. Svenmarker, S. Haggmark, E. Jansson, R. Lindholm, M. Appelblad, and T. Aberg
The relative safety of an oxygenator
Perfusion, September 1, 1997; 12(5): 289 - 292.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. L. Lazar, X. Zhang, T. Hamasaki, C. A. Memmelo, P. Treanor, S. Rivers, G. S. Aldea, S. A. Bernard, and R. J. Shemin
Heparin-Bonded Circuits Decrease Myocardial Ischemic Damage: An Experimental Study
Ann. Thorac. Surg., June 1, 1997; 63(6): 1701 - 1705.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
A. H. Kuitunen, L. J. Heikkila, and M. T. Salmenpera
Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation
Ann. Thorac. Surg., February 1, 1997; 63(2): 438 - 444.
[Abstract] [Full Text]


Home page
PerfusionHome page
H E Hogevold, O Moen, E Fosse, P Venge, J Braten, C Andersson, and T Lyberg
Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro
Perfusion, January 1, 1997; 12(1): 9 - 20.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. S. Aldea, M. Doursounian, P. O'Gara, P. Treanor, O. M. Shapira, H. L. Lazar, and R. J. Shemin
Heparin-Bonded Circuits With a Reduced Anticoagulation Protocol in Primary CABG: A Prospective, Randomized Study
Ann. Thorac. Surg., August 1, 1996; 62(2): 410 - 418.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. D. Muehrcke, P. M. McCarthy, K. Kottke-Marchant, H. Harasaki, J. Pierre-Yared, J. A. Borsh, D. A. Ogella, and D. M. Cosgrove
BIOCOMPATIBILITY OF HEPARIN-COATED EXTRACORPOREAL BYPASS CIRCUITS: A RANDOMIZED, MASKED CLINICAL TRIAL
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 472 - 483.
[Abstract] [Full Text]


Home page
PerfusionHome page
D. Royston
Surgery with cardiopulmonary bypass and pulmonary inflammatory responses
Perfusion, May 1, 1996; 11(3): 213 - 219.
[PDF]


Home page
PerfusionHome page
S. Daniel
Review on the multifactorial aspects of bioincompatibility in CPB
Perfusion, May 1, 1996; 11(3): 246 - 255.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. D. Muehrcke, P. M. McCarthy, R. W. Stewart, R. C. Foster, D. A. Ogella, J. A. Borsh, and D. M. Cosgrove III
Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock
Ann. Thorac. Surg., February 1, 1996; 61(2): 684 - 691.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.